Lite Strategy, Inc. Operating Leases, Rent Expense
Lite Strategy, Inc. (LITS) reported Operating Leases, Rent Expense of $67.00 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2019-08-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-08-28
- Lite Strategy, Inc. operating leases, rent expense for the quarter ending 2019-06-30 was -$25.00K.
- Lite Strategy, Inc. operating leases, rent expense for the quarter ending 2019-03-31 was $46.00K, a 4500.00% increase year-over-year.
- Lite Strategy, Inc. operating leases, rent expense for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Lite Strategy, Inc. operating leases, rent expense for the quarter ending 2018-09-30 was $46.00K, a 4.55% increase year-over-year.
- Lite Strategy, Inc. operating leases, rent expense for fiscal 2019 was $67.00K, a 45.65% increase from fiscal 2018.
- Lite Strategy, Inc. operating leases, rent expense for fiscal 2018 was $46.00K, a 4.55% increase from fiscal 2017.
- Lite Strategy, Inc. operating leases, rent expense for fiscal 2017 was $44.00K, a 51.72% increase from fiscal 2016.
- Lite Strategy, Inc. operating leases, rent expense for fiscal 2016 was $29.00K, a 7.41% increase from fiscal 2015.
| Period end | Operating Leases, Rent Expense 1 month | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|---|
| 2019-06-30 | -$25.00K derived: 10-K 12 month − 3 quarters · filed 2019-08-28 | $21.00K derived: sum of 2 quarters · filed 2019-08-28 | $21.00K derived: sum of 3 quarters · filed 2019-08-28 | $67.00K 10-K · filed 2019-08-28 | |
| 2019-03-31 | $46.00K 10-Q · filed 2019-05-09 | $46.00K derived: sum of 2 quarters · filed 2019-05-09 | $92.00K derived: sum of 3 quarters · filed 2019-05-09 | $92.00K derived: sum of 4 quarters · filed 2019-05-09 | |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $46.00K 10-Q · filed 2019-02-07 | $46.00K derived: sum of 3 quarters · filed 2019-02-07 | $47.00K derived: sum of 4 quarters · filed 2019-02-07 | |
| 2018-09-30 | $21.00K 10-Q · filed 2019-05-09 | $46.00K 10-Q · filed 2018-11-08 | $46.00K derived: sum of 2 quarters · filed 2018-11-08 | $47.00K derived: sum of 3 quarters · filed 2018-11-08 | $48.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-30 | $1.00K derived: sum of 2 quarters · filed 2018-08-30 | $2.00K derived: sum of 3 quarters · filed 2018-08-30 | $46.00K 10-K · filed 2018-08-30 | |
| 2018-03-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $2.00K derived: sum of 2 quarters · filed 2018-05-09 | $46.00K 10-Q · filed 2018-05-09 | $61.00K derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-12-31 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $45.00K 10-Q · filed 2018-02-08 | $60.00K derived: sum of 3 quarters · filed 2018-02-08 | $60.00K derived: sum of 4 quarters · filed 2018-02-08 | |
| 2017-09-30 | $44.00K 10-Q · filed 2017-11-08 | $59.00K derived: sum of 2 quarters · filed 2017-11-08 | $59.00K derived: sum of 3 quarters · filed 2017-11-08 | $59.00K derived: sum of 4 quarters · filed 2017-11-08 | |
| 2017-06-30 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-05 | $15.00K derived: sum of 2 quarters · filed 2017-09-05 | $15.00K derived: sum of 3 quarters · filed 2017-09-05 | $44.00K 10-K · filed 2017-09-05 | |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2017-05-04 | $29.00K 10-Q · filed 2017-05-04 | $31.00K derived: sum of 4 quarters · filed 2017-05-04 | |
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | $29.00K 10-Q · filed 2017-02-08 | $31.00K derived: sum of 3 quarters · filed 2017-02-08 | $31.00K derived: sum of 4 quarters · filed 2017-02-08 | |
| 2016-09-30 | $29.00K 10-Q · filed 2016-11-09 | $31.00K derived: sum of 2 quarters · filed 2016-11-09 | $31.00K derived: sum of 3 quarters · filed 2016-11-09 | $31.00K derived: sum of 4 quarters · filed 2016-11-09 | |
| 2016-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-06 | $2.00K derived: sum of 2 quarters · filed 2016-09-06 | $2.00K derived: sum of 3 quarters · filed 2016-09-06 | $29.00K 10-K · filed 2016-09-06 | |
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2016-05-05 | $27.00K 10-Q · filed 2016-05-05 | $27.00K derived: sum of 4 quarters · filed 2016-05-05 | |
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-05 | $27.00K 10-Q · filed 2016-02-05 | $27.00K derived: sum of 3 quarters · filed 2016-02-05 | ||
| 2015-09-30 | $27.00K 10-Q · filed 2015-11-06 | $27.00K derived: sum of 2 quarters · filed 2015-11-06 | |||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-02 | $27.00K 10-K · filed 2015-09-02 | |||
| 2015-03-31 | $27.00K 10-Q · filed 2015-05-07 | ||||
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-05-09 | $10.73K 10-Q · filed 2013-05-09 | ||
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-12 | $10.73K 10-Q · filed 2013-02-12 | |||
| 2012-09-30 | $10.73K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |